Doctor profile · Federal record
Dr. Larry di Fabrizio, MD
Pulmonary Disease Physician (CMS: Pulmonary Disease) · New York, NY
- NPI 1154393452
- Accepts Medicare
- 42 yrs in practice
- Male
- Group practice
- No sanctions
Practice & contact
Operates at 4 locations .
- Primary practice
-
10 E 102Nd St
New York, NY 10029
(212) 241-5656 - Additional location
-
1 Gustave L Levy Pl
New York, NY 100296504
(212) 241-5900 - Additional location
-
111 E 80Th St, Suite 1B
New York, NY 100210334
(212) 517-8488 - Additional location
-
5 E 98Th St
New York, NY 100296501 - Mailing address
-
1 Gustave L Levy Pl # 3000
New York, NY 100296504
Show 1 more location
Credentials & registration
- NPI registered
- February 2006 — 20 yrs on file
- Profile last updated
- February 27, 2019
- Year of graduation
- 1984 — 42 yrs since
- Specialty taxonomy
- 207RP1001X — NUCC code
- State license (1)
- New York #175377
Federal sanctions & exclusions
No sanctions, exclusions or revocations on file
Checked against OIG LEIE on NPI 1154393452. Last verified May 11, 2026.Medicare procedures · 2023
Top services delivered
Total services
3,595
Distinct HCPCS
9
Medicare allowed
$395,558
| HCPCS | Description | Services | Patients | Avg allowed | |
|---|---|---|---|---|---|
99233 |
Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | 1,354 | 166 | $136 | |
94375 |
Test to measure rate of airflow | 766 | 472 | $16 | |
99214 |
Established patient office or other outpatient visit, 30-39 minutes | 752 | 431 | $110 | |
99223 |
Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | 222 | 160 | $198 | |
99215 |
Established patient office or other outpatient visit, 40-54 minutes | 221 | 175 | $161 | |
99205 |
New patient office or other outpatient visit, 60-74 minutes | 129 | 129 | $205 | |
99214 |
Established patient office or other outpatient visit, 30-39 minutes | 94 | 83 | $111 | |
94729 |
Test to examine how well the lungs exchange gases | 41 | 38 | $10 | |
94726 |
Test to determine lung volumes using sensors | 16 | 15 | $13 |
In context: peer comparison
Among 108 peers in this city , average services per provider: 150. This provider delivers 24× the peer median.Medicare Part D · 2023
Top prescriptions
Total claims
2,755
Patients
812
Total drug cost
$744,578
| Drug | Type | Claims | Patients | Total cost |
|---|---|---|---|---|
| Fluticasone Propionate | Generic | 416 | 172 | $5,535 |
| Albuterol Sulfate Hfa (Albuterol Sulfate) | Brand | 347 | 122 | $12,629 |
| Trelegy Ellipta (Fluticasone/Umeclidin/Vilanter) | Brand | 343 | 76 | $260,428 |
| Breo Ellipta (Fluticasone/Vilanterol) | Brand | 332 | 78 | $175,088 |
| Montelukast Sodium | Generic | 220 | 54 | $3,580 |
| Symbicort (Budesonide/Formoterol Fumarate) | Brand | 189 | 53 | $79,123 |
| Incruse Ellipta (Umeclidinium Bromide) | Brand | 143 | 37 | $74,032 |
| Anoro Ellipta (Umeclidinium Brm/Vilanterol Tr) | Brand | 122 | 25 | $70,469 |
| Prednisone | Generic | 113 | 60 | $596 |
| Zolpidem Tartrate | Generic | 105 | 15 | $746 |
Hospital affiliations
Frequently asked questions
What is Dr. Larry di Fabrizio's medical specialty?
Dr. Larry di Fabrizio practices Pulmonary Disease Physician in New York, NY.
Where does Dr. Larry di Fabrizio practice?
Dr. Larry di Fabrizio practices at 10 E 102Nd St, New York, NY 10029. Office phone: 2122415656.
What is Dr. Larry di Fabrizio's NPI?
Dr. Larry di Fabrizio's National Provider Identifier (NPI) is 1154393452, issued by NPPES.
Does Dr. Larry di Fabrizio accept Medicare assignment?
Yes. Dr. Larry di Fabrizio accepts Medicare assignment, meaning Medicare-allowed amounts are accepted as full payment for covered services.
What procedures does Dr. Larry di Fabrizio commonly perform?
Top Medicare-reported procedures in 2023: Subsequent hospital care with moderate levelof medical decision making (HCPCS 99233); Test to measure rate of airflow (HCPCS 94375); Established patient office or other outpatient visit (HCPCS 99214). Source: CMS Medicare Physician & Other Practitioners file.